« Return to News | Awards & Advancement

Novavax appoints Stanley C. Erck as president and CEO

Wednesday, April 20, 2011 12:02 PM

Novavax’s Stanley C. Erck, its former executive chairman, has been appointed to the position of president and chief executive officer and will remain as a member of the board of directors. Current board member James Young, Ph.D., will assume the position of chairman of the board.

Erck has had experience in the biotechnology sector and has brought infectious disease product candidates into late-stage clinical trials for Novavax. From 2000-2008, Erck served as president and CEO of Iomai Corporation, leading the company through an IPO and a merger with Intercell. He also served as president and CEO of Procept, a publicly-traded immunology company; as vice president of corporate development at Integrated Genetics, and in management positions within Baxter International.

Young has over 30 years of experience in the fields of molecular genetics, microbiology, immunology and pharmaceutical development. He was previously president of R&D at MedImmune where he was instrumental in the development of FluMistR and SynagisR.

 

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.